MHLW Greatly Reduces Funding For Unapproved Drug Development
This article was originally published in PharmAsia News
Executive Summary
Japan's new administration has decided to halt implementation of supplementary budgets for fiscal year 2009, and one area affected is funding to support not-yet-approved drugs